Kairos Pharma
KAPA • XASE
Kairos Pharma is a pharmaceutical preparations company trading on XASE, led by CEO John S. Yu, with a market cap of $14.1M.
Market Cap$14.1M
CEOJohn S. Yu
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 13, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Kairos Pharma FAQ
Common questions about Kairos Pharma
Kairos Pharma is scheduled to report earnings for Q1 2026 on May 13, 2026 before market open.